Pulse nav.journalClub 活発な議論トレンド探索質問研究者

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

プライバシーポリシー

ホーム探索 nav.journalClub トレンド

⌘+K

Early Experience Treating Vestibular Migraine With Small Molecule CGRP Antagonists. | Synapse

March 6, 2026

Early Experience Treating Vestibular Migraine With Small Molecule CGRP Antagonists.

Key Points

To evaluate the effectiveness of small molecule CGRP antagonists in treating vestibular migraine.
Overview of gepant use for vestibular migraine management
Assessment of patient tolerance to gepants
Gepants are well-tolerated by patients
Gepants show promise as effective agents for vestibular migraine treatment

Abstract

Gepants are well-tolerated by patients and are promising agents for the treatment of vestibular migraine.

Like

Bookmark

Share

Cite This Study

Patel et al. (Tue,) studied this question.

synapsesocial.com/papers/69aa7037531e4c4a9ff59cb2 https://doi.org/https://doi.org/10.1002/ohn.70196

Like

Bookmark

Share